The estimated Net Worth of Joseph Todisco is at least $3.75 Milion dollars as of 13 March 2024. Mr Todisco owns over 13,561 units of Amneal Pharmaceuticals Inc stock worth over $2,949,734 and over the last 6 years he sold AMRX stock worth over $6,150. In addition, he makes $790,123 as Exec. VP & Chief Commercial Officer of Specialty at Amneal Pharmaceuticals Inc.
Mr has made over 15 trades of the Amneal Pharmaceuticals Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he bought 13,561 units of AMRX stock worth $50,718 on 13 March 2024.
The largest trade he's ever made was exercising 40,794 units of Amneal Pharmaceuticals Inc stock on 27 February 2021 worth over $341,038. On average, Mr trades about 10,902 units every 71 days since 2019. As of 13 March 2024 he still owns at least 352,839 units of Amneal Pharmaceuticals Inc stock.
You can see the complete history of Mr Todisco stock trades at the bottom of the page.
Joseph Todisco MBA is the Exec. VP & Chief Commercial Officer of Specialty at Amneal Pharmaceuticals Inc.
As the Exec. VP & Chief Commercial Officer of Specialty of Amneal Pharmaceuticals Inc, the total compensation of Mr MBA at Amneal Pharmaceuticals Inc is $790,123. There are 5 executives at Amneal Pharmaceuticals Inc getting paid more, with Andrew Boyer having the highest compensation of $3,113,080.
Mr MBA is 45, he's been the Exec. VP & Chief Commercial Officer of Specialty of Amneal Pharmaceuticals Inc since . There are 19 older and 2 younger executives at Amneal Pharmaceuticals Inc. The oldest executive at Amneal Pharmaceuticals Inc is Shlomo Yanai, 67, who is the Independent Director.
Joseph's mailing address filed with the SEC is C/O CORMEDIX INC., 300 CONNELL DRIVE, SUITE 4200, BERKELEY HEIGHTS, NJ, 07922.
Over the last 7 years, insiders at Amneal Pharmaceuticals Inc have traded over $867,197,480 worth of Amneal Pharmaceuticals Inc stock and bought 3,818,425 units worth $12,997,905 . The most active insiders traders include Gp A, Llcbonderman Davidcou..., Holdings, Llc Aphc oraz International Ltd Fosun. On average, Amneal Pharmaceuticals Inc executives and independent directors trade stock every 18 days with the average trade being worth of $3,857,739. The most recent stock trade was executed by Andrew S Boyer on 14 August 2024, trading 62,711 units of AMRX stock currently worth $491,654.
an american pharmaceutical company, amneal develops and produces affordable medicines. the company was built upon a family tradition of quality and integrity. everything amneal does, across the full spectrum of its business, is in service to these guiding principles. amneal is committed to constantly elevating and refining the value it delivers to its customers and patients around the globe.
Amneal Pharmaceuticals Inc executives and other stock owners filed with the SEC include: